These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21867814)

  • 21. Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations.
    Burkhardt O; Kumar V; Schmidt S; Kielstein JT; Welte T; Derendorf H
    Int J Antimicrob Agents; 2010 Jan; 35(1):96-7. PubMed ID: 19896806
    [No Abstract]   [Full Text] [Related]  

  • 22. Aerosolized antibiotics in the intensive care unit.
    Palmer LB
    Clin Chest Med; 2011 Sep; 32(3):559-74. PubMed ID: 21867823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
    Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
    Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of levofloxacin in critically ill patients with ventilator-associated pneumonia.
    Benko R; Matuz M; Doro P; Peto Z; Molnar A; Hajdu E; Nagy E; Gardi J; Soos G
    Int J Antimicrob Agents; 2007 Aug; 30(2):162-8. PubMed ID: 17570646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De-escalation therapy in ventilator-associated pneumonia.
    Niederman MS
    Curr Opin Crit Care; 2006 Oct; 12(5):452-7. PubMed ID: 16943725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De-escalation therapy: is it valuable for the management of ventilator-associated pneumonia?
    Niederman MS; Soulountsi V
    Clin Chest Med; 2011 Sep; 32(3):517-34. PubMed ID: 21867820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy for hospital-acquired pneumonia.
    Liapikou A; Rosales-Mayor E; Torres A
    Expert Opin Pharmacother; 2014 Apr; 15(6):775-86. PubMed ID: 24579912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.
    Jones RN
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S81-7. PubMed ID: 20597676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. End points in hospital-acquired pneumonia and/or ventilator-associated pneumonia clinical trials: food and drug administration perspective.
    Laessig KA
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S117-9. PubMed ID: 20597659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit.
    Chastre J; Luyt CE; Combes A; Trouillet JL
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S75-81. PubMed ID: 16894519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines.
    File TM
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S42-7. PubMed ID: 20597671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pneumonia in immunocompetent patients: combination antibiotic therapy.
    Salva S; Borgatta B; Rello J
    Minerva Anestesiol; 2014 Apr; 80(4):495-503. PubMed ID: 24122034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?
    Pea F; Viale P
    Clin Infect Dis; 2006 Jun; 42(12):1764-71. PubMed ID: 16705585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients.
    Li C; Kuti JL; Nightingale CH; Nicolau DP
    J Clin Pharmacol; 2006 Oct; 46(10):1171-8. PubMed ID: 16988206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tackling empirical antibiotic therapy for ventilator-associated pneumonia in your ICU: guidance for implementing the guidelines.
    Kuti JL; Shore E; Palter M; Nicolau DP
    Semin Respir Crit Care Med; 2009 Feb; 30(1):102-15. PubMed ID: 19199192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concerns regarding the methodology of the study entitled "Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?".
    Suzuki H; Kagawa H; Iwata K
    J Trauma; 2009 Nov; 67(5):1133; author reply 1133-4. PubMed ID: 19901690
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia.
    Lagacé-Wiens PR; Rubinstein E
    Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):789-99. PubMed ID: 23590397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early-onset pneumonia after liver transplantation: microbiological findings and therapeutic consequences.
    Weiss E; Dahmani S; Bert F; Janny S; Sommacale D; Dondero F; Francoz C; Belghiti J; Mantz J; Paugam-Burtz C
    Liver Transpl; 2010 Oct; 16(10):1178-85. PubMed ID: 20879016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment options for nosocomial pneumonia due to MRSA.
    Niederman MS
    J Infect; 2009 Sep; 59 Suppl 1():S25-31. PubMed ID: 19766886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing antibiotic dosing regimens for nosocomial pneumonia: a window of opportunity for pharmacokinetic and pharmacodynamic modeling.
    Shen Y; Kuti JL
    Expert Opin Drug Metab Toxicol; 2023 Jan; 19(1):13-25. PubMed ID: 36786064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.